Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE opened at $0.10 on Tuesday. Ampio Pharmaceuticals has a 12-month low of $0.07 and a 12-month high of $8.30. The stock has a market cap of $113,500.00, a price-to-earnings ratio of -0.01 and a beta of 2.21. The business has a 50 day moving average of $0.20 and a 200-day moving average of $1.07.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.